Erectile Dysfunction and Low Testosterone
Erectile dysfunction affects roughly 5% of cases primarily due to low testosterone, though the connection is more complex than most men realize.1 ED isn't the most predictive symptom of hypogonadism — fatigue and reduced libido rank higher — but European clinical guidelines recommend testosterone testing in every man presenting with erectile difficulties.2
The reason is dose-dependent. Men with testosterone below 231 ng/dL show significantly greater erectile function improvement than those in the 231-346 ng/dL range.1 Low testosterone disrupts multiple penile pathways simultaneously: phosphodiesterase-5 (PDE5) expression, nitric oxide signaling, and smooth muscle function in the corpus cavernosum. Normalizing testosterone to eugonadal levels — 300-1000 ng/dL — maximizes responsiveness to PDE5 inhibitors like sildenafil and addresses the hormonal component of erectile dysfunction.
How Testosterone Affects Erections
Testosterone regulates several biological systems that make erections possible. When levels drop below 300 ng/dL, these pathways deteriorate in measurable ways.
Biological Pathways
Testosterone controls phosphodiesterase-5 (PDE5) expression in penile tissue — the enzyme system that maintains the nitric oxide balance needed for vasodilation during erection.1 In the corpus cavernosum, testosterone deficiency triggers increased collagen deposition and impaired smooth muscle relaxation, making the tissue less responsive to arousal signals. The hypothalamic-pituitary-gonadal (HPG) axis links testosterone to androgen receptor signaling in penile vasculature and nerves.2 When testosterone drops, sex hormone-binding globulin (SHBG) often rises, further limiting free testosterone availability and amplifying the dysfunction.
Testosterone Levels & Response
The relationship between testosterone and erectile function is dose-dependent. Men with baseline testosterone below 231 ng/dL experience a 2.95-point improvement on the International Index of Erectile Function (IIEF-EF) scale with treatment, compared to 1.47 points for men in the 231-346 ng/dL range.1 Normalizing testosterone to eugonadal states — 300-1000 ng/dL — maximizes PDE5 inhibitor responsiveness, meaning sildenafil and similar medications work better when testosterone is adequate. Severity correlates inversely with testosterone levels: the lower the testosterone, the more pronounced the erectile dysfunction.
Vasculogenic ED, the predominant form, often has a hormonal component that goes unrecognized. Testosterone deficiency affects endothelial function throughout the vascular system, not just in the penis.
This explains why cardiovascular risk factors and Low Testosterone frequently co-occur in men with ED. Addressing testosterone alone may not resolve ED caused by atherosclerosis or diabetes, but it removes one major obstacle to normal erectile function.
Phosphodiesterase-5 (PDE5) is an enzyme in penile tissue that regulates nitric oxide levels to control blood vessel relaxation and constriction during erection. PDE5 inhibitors like sildenafil work by blocking this enzyme to enhance erectile function.
Hypothalamic-Pituitary-Gonadal (HPG) Axis is the regulatory system connecting the brain to the testes that controls testosterone production and release. It links testosterone signaling to blood vessel and nerve function throughout the body.
Recognizing ED Symptoms
Erectile dysfunction due to low testosterone presents differently than ED from vascular or psychological causes. Knowing which pattern fits your experience helps guide testing.
Low-T ED Signs
Gradual onset of difficulty maintaining erection, reduced morning and nocturnal erections, decreased rigidity even when libido is normal.
Red Flags for Other Causes
Acute sudden onset, persistent morning erections despite ED during sex, abnormal Doppler ultrasound showing poor penile blood flow.
Timeline Clues
Gradual worsening over months to years suggests hormonal contribution. Sudden loss of function points to vascular or psychological factors.
When to Test T Levels
Any ED presentation warrants testosterone screening per European guidelines, regardless of whether other causes seem obvious.2
Low testosterone is the primary cause in only 5% of ED cases.1 Vasculogenic causes — atherosclerosis from diabetes, hypertension, smoking — account for the majority. Neurologic issues like multiple sclerosis or spinal cord injury, psychogenic factors like anxiety or depression, and medications like beta-blockers or antidepressants all produce erectile dysfunction independent of hormone levels.
Lifestyle factors complicate the picture. Obesity and sedentary behavior drive insulin resistance and endothelial dysfunction, mimicking hypogonadal effects on erectile tissue. The absence of morning erections, failure of nocturnal penile tumescence on testing, or poor penile blood flow on Doppler ultrasound suggest non-hormonal causes that won't fully respond to testosterone treatment alone.2
TRT Response for ED
Testosterone replacement therapy improves erectile function in hypogonadal men, but the timeline and magnitude vary based on baseline levels and concurrent health issues.
Meta-analyses of 14 randomized controlled trials show a mean 2.31-point improvement on the IIEF-EF scale versus placebo — clinically meaningful for mild ED, which requires a 2-point gain.1 The Testosterone Trials in older men with low testosterone reported 2.64-point gains after one year of Testosterone Gel. Improvements typically appear 4-12 weeks into treatment, with full response taking 6-12 months.
Men with baseline testosterone below 231 ng/dL show the greatest gains. In observational studies tracking 805 hypogonadal men, 36% reported improved erectile function and 42% showed penile vascular improvements.3 Moderate to severe ED dropped from 67% to 19% on the IIEF scale, with maximal effects by 6-9 months and continued yearly gains through year 9 in half the cohort.
One patient on TRT described the change: "It's been over a year and a half since starting TRT and my sex life has done a 180. Two weeks after starting treatment, I initiated sex for the first time in 6 months and was able to perform."4
Combination therapy produces better results than TRT alone. Randomized trials show 60-70% response rates when testosterone is combined with PDE5 inhibitors like sildenafil in men with severe hypogonadism, versus failure on PDE5 inhibitors alone.2 Normalization of testosterone to eugonadal range improves PDE5 inhibitor responsiveness — the medications work better when testosterone is adequate.
Non-responders include men with normal baseline testosterone, severe vascular comorbidity, or incomplete testosterone normalization. Predictors of response are baseline total testosterone below 300 ng/dL, free testosterone under 50 pg/mL, and absence of diabetes.5 TRT addresses the hormonal component, but concurrent vasculogenic or psychogenic issues require additional treatment.
Lifestyle Strategies
Non-hormonal interventions support erectile function and often enhance TRT response. These strategies address the vascular and metabolic factors that overlap with testosterone deficiency.
Regular Exercise
Improves endothelial function and reduces insulin resistance. Aerobic exercise and resistance training synergize with TRT to enhance vascular health in penile tissue.
Weight Management
Obesity exacerbates ED through endothelial dysfunction independent of testosterone levels. Weight loss improves erectile outcomes even before testosterone normalizes.
Cardiovascular Health
Smoking cessation, blood pressure control, and managing atherosclerosis risk reduce vasculogenic ED. These factors often limit TRT response if unaddressed.
Sleep Quality
Seven to nine hours per night supports testosterone production and vascular health. Sleep apnea, common in hypogonadal men, worsens both low testosterone and ED.
Stress Reduction
Addresses the psychogenic component of ED, which often coexists with hormonal causes. Anxiety and depression interfere with sexual function independent of testosterone levels.